Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of chitosan-based norcantharidin derivatives in the preparation of antitumor compositions

A technology of chitosan derivatives and norcantharidin, which is applied in the field of medicine and biology, can solve the problems of increased toxicity, short absorption and elimination time, and reduced tumor treatment effect, so as to reduce toxic side effects, reduce drug dosage, and long retention time Effect

Active Publication Date: 2018-03-27
OCEAN UNIV OF CHINA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the toxicity of norcantharidin has been reduced, it still has toxicity to the urinary system. At the same time, it is widely distributed in the body and has a short absorption and elimination time, which reduces its therapeutic effect on tumors and increases its effect on other organs. organ toxicity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of chitosan-based norcantharidin derivatives in the preparation of antitumor compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Embodiment 1: Preparation of chitosan-based norcantharidin derivatives

[0023] Chitosan-based norcantharidin derivatives were prepared by reacting water-soluble carboxymethyl chitosan, hydroxyethyl chitosan, and hydroxypropyl chitosan as substrates with norcantharidin. The specific preparation process as follows:

[0024] (1) Preparation of chitosan-based norcantharidin derivative 1: Weigh 1.0 g carboxymethyl chitosan (95.5% carboxymethyl substitution degree, 83.2% deacetylation degree, 96.5 kD molecular weight, mol number of sugar units 0.0033 mol), placed in a 50ml three-necked flask, added 25ml of distilled water, stirred to dissolve, added triethylamine to adjust the pH to 9, and obtained carboxymethyl chitosan solution. Weigh 2.2g norcantharidin (0.012 mol), dissolve it in 10ml acetone to obtain norcantharidin acetone solution. Add the norcantharidin acetone solution dropwise into the carboxymethyl chitosan solution under stirring, react at room temperature and ...

Embodiment 2

[0038] Embodiment 2: Chitosan-based norcantharidin derivatives inhibit the growth of tumor tissue

[0039] The experimental animals were Kunming mice, half male and half male, weighing 18-20 g. Resuscitate mouse liver cancer cells H22, after routine culture of cells, adjust the cell density to 1.0×10 with normal saline 7 / ml, inoculated in the abdominal cavity of primary mice, 0.5 ml / only. Five to seven days after inoculation, the cells were subcultured in the abdominal cavity for 3 consecutive generations. H22 tumor-bearing mice with good growth in the abdominal cavity were taken and sacrificed by cervical dislocation. The ascites tumor fluid was extracted under sterile conditions, centrifuged, and the cell density was adjusted to 2.0×10 with normal saline. 7 / ml, inoculated subcutaneously in the left forelimb armpit of normal mice, 0.2 ml each, to make mouse H22 tumor-bearing models.

[0040] After 24 hours of modeling, tumor-bearing mice were randomly divided into gro...

Embodiment 3

[0053] Embodiment 3: excretion of chitosan-based norcantharidin derivatives

[0054] Taking rats as experimental animals, they were randomly divided into 7 groups, with 3 rats in each group:

[0055] Normal saline control group: give normal saline;

[0056] Experiment 1 group: give chitosan-based norcantharidin derivative 1 physiological saline solution;

[0057] Experiment 2 group: give chitosan-based norcantharidin derivative 2 physiological saline solution;

[0058] Experiment 3 group: give chitosan-based norcantharidin derivative 3 physiological saline solution;

[0059] Experiment 4 group: give chitosan-based norcantharidin derivative 4 physiological saline solution;

[0060] Experimental group 5: given the physiological saline solution of chitosan-based norcantharidin derivative 5;

[0061] Experiment 6 group: give chitosan-based norcantharidin derivative 6 physiological saline solution;

[0062] Norcantharidin control group: Norcantharidin normal saline solution wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
degree of substitutionaaaaaaaaaa
degree of substitutionaaaaaaaaaa
degree of substitutionaaaaaaaaaa
Login to View More

Abstract

The invention discloses the application of a chitosan-based norcantharidin derivative in the preparation of an anti-tumor composition. The chitosan-based norcantharidin derivative is carboxymethyl chitosan norcantharidin Derivatives, hydroxyethyl chitosan norcantharidin derivatives or hydroxypropyl norcantharidin derivatives, carboxymethyl, hydroxyethyl or The molar percentage of hydroxypropyl group is greater than 50%, and the molar percentage of norcantharidin derivative is not less than 10%. Chitosan-based norcantharidin derivatives of the present invention have a significant effect of inhibiting tumor tissue growth, and its effect is better than that of norcantharidin, and the retention time in the body is long, thereby reducing the dosage of norcantharidin, The toxic and side effects are reduced, the toxicity is attenuated and the effect is increased, and the application in the preparation of drugs for inhibiting and treating anti-tumor, medical equipment, health food and biological preparations has broad prospects.

Description

technical field [0001] The invention belongs to the technical field of medicine and biology, and relates to a chitosan-based norcantharidin derivative and its application in preparing a composition for inhibiting and treating tumors. Background technique [0002] Malignant tumors seriously endanger human health, ranking first among major diseases, with extremely high mortality. As a developing country in my country, with the acceleration of population aging process and the existence of environmental pollution problems, the incidence of malignant tumors continues to rise, and the situation of cancer prevention and treatment is very severe. [0003] Norcantharidin (norcantharidin, NCTD) is a derivative of cantharidin, the active ingredient of cantharidin, and is a drug developed in my country for the treatment of cancer. Compared with cantharidin, norcantharidin has less nephrotoxicity and stimulating effect on the urinary system, at the same time, it has the effect of increa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61K31/722A61P35/00C08B37/08C07H13/10
Inventor 韩宝芹蒋志雯彭燕飞刘万顺
Owner OCEAN UNIV OF CHINA